Hematopoietic Stem Cell Committee

Charter

The  Hematopoietic Stem Cell Committee strives to:

  • Assist in the planning of the annual meeting scientific program and the review of submitted abstracts in the hematopoietic stem cell field.
  • Review the status of the hematopoietic stem cell field and compile a list of major scientific issues that must be addressed to advance or enable emerging cell therapies.
  • Publish position papers and engage in scientific discourse as necessary to advance the field.

Projects and Objectives

  • Publish one review or position paper on the current practice of Hematopoietic Stem Cells.
  • Contribute topics and speakers to the ISCT Annual Meeting.

 Committee Members:


 

EJ Shpall, MD
Chair
MD Anderson Cancer Center
Houston, TX, United States

Juliet Barker, MD
University of Minnesota Medical Center
Minneapolis, MN, United States
Catherine Bollard, MBChB, MD
Children's National Health System
Washington, DC, United States

Willem Fibbe, MD, PhD
Leiden University Medical Centre
Leiden, The Netherlands
Eliane Gluckman, MD, PhD
University of Paris
Paris, France
Katy Rezvani, MD, PhD
MD Anderson Cancer Center
Houston, TX, United States

Katerina LeBlanc, MD, PhD
Karolinska Institute
Stockholm, Sweden

Ian McNiece, PhD
MD Anderson Cancer Center
Houston, TX, United States

Mohamad Mohty, MD, PhD
University Pierre & Marie Curie
Paris, France



 

© 2015 International Society for Cellular Therapy. All rights reserved.
ISCT, International Society for Cellular Therapy, and the ISCT logo are registered service marks of The International Society for Cellular Therapy.
The BEACON and lighthouse logo is a service mark of The International Society for Cellular Therapy.